- Home
- Life Sciences
- Pharmaceutical
- Drug and Medication
- Drug and Medication Analysis & Statistics in Spain, January 2013 (p2)
Talk to Alison
00 1 718 618 48 97
Search inside this page
Publication dates
Publishers
- Global Data (36)
- Global Research & Data Services (5)
- Business Monitor International (30)
- Datamonitor (19)
- VacZine Analytics Group Of Assay Advantage Ltd (10)
-
- Euromonitor International (5)
- SCRIP Insights (3)
- Espicom Business Intelligence (2)
- GBI Research (2)
- Aruvian's R'search (1)
- DrugPatentWatch - ThinkBiotech LLC (1)
- Global Industry Analyst (1)
- Ken Research Private (1)
- Visiongain (1)
data types
Free Market Research Guides to Download
Drug and Medication Analysis & Statistics in Spain, January 2013 (p2)
You might be interested in: drug, vaccine, insulin, more »
» Purchase Premium Reports
31-70 of 91 reports
Spain Vaccine Exports, Eurmn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2008
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : Spain
Spain Vaccine Exports, Eurmn, % Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2009
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : Spain
Spain Vaccine Imports, Us$mn, % Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2009
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : Spain
Spain Vaccine Imports, Eurmn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2008
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : Spain
Spain Vaccine Exports, Us$mn, % Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2009
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : Spain
Spain Pharmaceutical Sales, % Of Gdp
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: Association of the European Self-Medication Industry (AESGP), IMS Health, Spanish Association for Se
- Industries : Drug and Medication
- Countries : Spain
Spain Pharmaceutical Sales, Eurbn, % Chg Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2005 To 2021
By Business Monitor International
Source: Association of the European Self-Medication Industry (AESGP), IMS Health, Spanish Association for Se
- Industries : Drug and Medication
- Countries : Spain
Spain Pharmaceutical Sales At Constant Exchange Rate, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: Association of the European Self-Medication Industry (AESGP), IMS Health, Spanish Association for Se
- Industries : Drug and Medication
- Countries : Spain
Spain Pharmaceutical Sales, Us$ Per Capita
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: Association of the European Self-Medication Industry (AESGP), IMS Health, Spanish Association for Se
- Industries : Drug and Medication
- Countries : Spain
Spain Pharmaceutical Sales, Us$bn, % Chg Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2005 To 2021
By Business Monitor International
Source: Association of the European Self-Medication Industry (AESGP), IMS Health, Spanish Association for Se
- Industries : Drug and Medication
- Countries : Spain
MarketVIEW: Herpes Simplex Virus vaccines (therapeutic)
- $ 8 995
- Industry report
- July 2012
- by VacZine Analytics Group Of Assay Advantage Ltd
Herpes Simplex Virus (HSV) is a sexually transmitted virus which is a major cause of genital herpes (GH). Although most individuals infected with HSV-2 have minimal signs of infection, the disease is ...
- Industries : Drug and Medication
- Countries : United States, United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, World
Biopharmaceutical: Hepatitis A Preventive Vaccines
- $ 3 995
- Company report
- June 2012
- by Global Data
GlobalData, the market analysis specialist, has released its new report, ??. The report is an essential source of information and analysis on the global Hepatitis A Preventive Vaccines industry . The ...
- Industries : Drug and Medication
- Countries : Japan, Spain, Italy, France, Germany, United States, World, Europe, United Kingdom
MarketVIEW: Chlamydia trachomatis vaccines
- $ 8 995
- Industry report
- June 2012
- by VacZine Analytics Group Of Assay Advantage Ltd
Chlamydia trachomatis (CT) is an intracellular Gram-negative bacterium and a leading cause worldwide of sexually-transmitted disease and preventable blindness. The pathogen is a major cause of serious ...
- Industries : Drug and Medication
- Countries : Australia, World, Brazil, United States, Mexico, Canada, United Kingdom, Spain, Russian Federation, Italy, France, Germany, Japan, India, China, Europe
MarketVIEW: Cytomegalovirus vaccines
- $ 9 995
- Industry report
- June 2012
- by VacZine Analytics Group Of Assay Advantage Ltd
Cytomegalovirus (CMV) is a member of the herpesvirus family and is widely prevalent throughout the population. In the US around 50-80% of adults are infected by 40 years of age (US CDC figures) whereas ...
- Industries : Drug and Medication
- Countries : United States, Canada, Spain, Italy, France, Germany, Japan, Europe, United Kingdom, World
Market and Product Projections : Non-Insulin Antidiabetics ? - Incretin mimetics face off Market Overview in type 2 diabetes
- $ 11 400
- Industry report
- May 2012
- by Datamonitor
The 2011'20 projection period will see the loss of exclusivity for the leading non-insulin antidiabetic Actos franchise, while new launches include the first once-weekly GLP-1 agonists and the oral SGLT-2 ...
- Industries : Drug and Medication
- Countries : Japan, Spain, Italy, France, Germany, United States, Europe, United Kingdom
Cough, Cold and Allergy (hay Fever) Remedies Market Overview in Spain
- $ 898
- Industry report
- May 2012
- by Euromonitor International
The initial outbreak of H1N1 influenza observed in Mexico in the first quarter of 2009 caused global concerns due to fears of the potential deadly consequences on humans. In Spain, until October the incidence ...
- Industries : Drug and Medication
- Countries : Spain
Nrt Smoking Cessation Aids Market Overview in Spain
- $ 898
- Industry report
- May 2012
- by Euromonitor International
One of the primary effects of the economic slowdown in Spain has been a moderation in spending by consumers with modest incomes, especially on non-essential goods. As a result, sales through pharmacies ...
- Industries : Drug and Medication
- Countries : Spain
Analgesics Market Overview in Spain
- $ 898
- Industry report
- May 2012
- by Euromonitor International
As the unemployment rate approached 18% at the end of the review period, Spaniards? shopping habits demonstrated change, with price the key variable taken into account when making purchasing decisions. ...
- Industries : Drug and Medication
- Countries : Spain
Digestive Remedies Market Overview in Spain
- $ 898
- Industry report
- May 2012
- by Euromonitor International
2009 sales were the result of two divergent factors. First the increase in the stress suffered by Spaniards as a consequence of the economic crisis resulted in a rise d number of Spaniards suffering digestive ...
- Industries : Drug and Medication
- Countries : Spain
Insulin - Spain
- $ 652
- Industry report
- May 2012
- by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for insulin in Spain. The study provides essential market information for decision-makers including: ...
- Industries : Drug and Medication
- Countries : Spain
MarketVIEW: Staphylococcus aureus vaccines
- $ 9 995
- Industry report
- April 2012
- by VacZine Analytics Group Of Assay Advantage Ltd
Gram-positive Staphylococcus aureus is an opportunistic pathogen and a major cause of patient morbidity and mortality, especially in "at risk" populations. The organism can cause a wide range of infections ...
- Industries : Drug and Medication
- Countries : United States, France, Germany, Europe, Australia, Canada, United Kingdom, Spain, Italy, Japan, World
Auro Laboratories Limited (Symbol:530233) SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- March 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Drug and Medication
- Countries : Singapore, South Africa, World, Brazil, United States, Spain, Germany, Malaysia, India, Egypt
Vaccines - Spain
- $ 652
- Industry report
- March 2012
- by Global Research & Data Services
This market research report offers an in-depth perspective on the actual market situation, trends and future outlook for vaccines in Spain. The analysis provides essential market information for decision-makers ...
- Industries : Drug and Medication
- Countries : Spain
Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019
- $ 3 995
- Company report
- February 2012
- by Global Data
Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, ?Haemophilus Influenzae ...
- Industries : Drug and Medication
- Countries : World, Japan, Spain, Italy, France, Germany, United States, Europe, United Kingdom
Pharmaceutical Industry in Spain
- $ 300
- Industry report
- February 2012
- by Aruvian's R'search
The birth origins of the Pharmaceutical Industry can be traced back to more humble antecedents than just chemistry labs. The earliest incidents of recognition of the antiseptic properties of the dyestuffs ...
- Industries : Drug and Medication
- Countries : Spain
MarketVIEW: Universal pneumo vaccines
- $ 9 995
- Industry report
- January 2012
- by VacZine Analytics Group Of Assay Advantage Ltd
Vaccines to prevent serious infections caused by Streptococcus pneumoniae or "pneumo" currently form the largest component of the global vaccine market ($4 - 5bn/yr). Notable examples are Prevnar/Prevena ...
- Industries : Drug and Medication
- Countries : South Korea, Europe, World, Australia, Netherlands, United States, Canada, Spain, Portugal, Poland, Italy, Greece, France, Germany, Belgium, Japan, United Kingdom, Bangladesh, Brazil, Mexico, Gambia
Spain Drug Patent Inventor Report - 2011
- $ 195
- Industry report
- January 2012
- by DrugPatentWatch - ThinkBiotech LLC
Profiles Spanish drug inventors who have received USPTO patents for FDA-approved drugs since 2000
- Industries : Drug and Medication
- Countries : Spain
Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
- $ 3 500
- Industry report
- December 2011
- by Global Data
Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData's new report, ?Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive ...
- Industries : Drug and Medication
- Countries : World, Australia, Spain, Italy, France, Germany, India, China, Europe, United Kingdom, Oceania, Asia
Market and Product Projections : COPD - ? Growth expected despite untapped industry potential
- $ 11 400
- Industry report
- November 2011
- by Datamonitor
About This Report New product launches for COPD across the seven major industry s will override generic erosion and boost industry value from USD 8.2bn in 2011 to USD 9.6bn by 2020, representing a positive ...
- Industries : Drug and Medication
- Countries : Spain, Italy, France, Germany, Japan
Drug and Medication: Hepatitis B Vaccines
- $ 3 500
- Industry report
- October 2011
- by Global Data
GlobalData, the market analysis specialist, has released its new report, ?Hepatitis B - Pipeline Assessment and Industry Projections to 2017?. The report is an essential source of information and analysis ...
- Industries : Drug and Medication
- Countries : World, Japan, Spain, Italy, France, Germany, United States, Europe, United Kingdom
Drug and Medication in Italy: 5EU: Pricing, Reimbursment and Regulatory Update
- $ 1 900
- Industry report
- October 2011
- by Datamonitor
About This Report Governments across the five major EU industry s (France, Germany, Italy, Spain, and the UK) have been busy implementing regulatory, pricing, and reimbursement reforms in 2011. Price cuts ...
- Industries : Drug and Medication
- Countries : Italy, Spain, Germany, France, Europe, United Kingdom
World Biopharmaceutical: Cancer Vaccines
- $ 3 500
- Industry report
- October 2011
- by Global Data
The report identifies major industry developments shaping and driving the global Atopic dermatitis disease industry . It also provides insight on the prevalent competitive landscape and the emerging players ...
- Industries : Drug and Medication
- Countries : Japan, Spain, Italy, France, Germany, World, United States, Europe, United Kingdom
Influenza Vaccines Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- $ 3 500
- Industry report
- October 2011
- by Global Data
Influenza Vaccines Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, ?Influenza Vaccines Therapeutics - ...
- Industries : Drug and Medication
- Countries : Japan, Spain, Italy, France, Germany, World, United States, Europe, United Kingdom
Product Profiles: HIV - Growing number of FDCs further commoditizes the HIV industry
- $ 11 400
- Industry report
- October 2011
- by Datamonitor
About This Report Gilead's/Bristol-Myers Squibb's Atripla was the first industry ed cross-class fixed dose combination (FDC), an antiretroviral drug class in which drugs from different drug classes are ...
- Industries : Drug and Medication
- Countries : Spain, Italy, France, Germany, Europe, United States, United Kingdom
Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020 Summary GlobalData's pharmaceuticals report, ?Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020? provides ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020 Summary GlobalData's pharmaceuticals report, ?Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020? provides Macitentan ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020 Summary GlobalData's pharmaceuticals report, ?Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020? provides ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020 Summary GlobalData's pharmaceuticals report, ?Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020? provides Veletri sales ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020 Summary GlobalData's pharmaceuticals report, ?Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020? provides Adcirca sales estimates ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020 Summary GlobalData's pharmaceuticals report, ?Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020? provides Revatio sales estimates ...
- Industries : Drug and Medication
- Countries : Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
» Download Public Reports
43 reports
Spain: Brief Outlook, 2013, focus on Drug and Medication
- Country report
- February 2013
- 5 pages
... And payer [20]. A canadian study showed that despite fingolimod having a greater reduc- tion in the annual relapse rate, it has the same net health benefit as treatment with interferon beta-1b [21 ...
Drug And Medication Sector Analysis In China And Europe
November 2011The Spanish Drug And Medication Business Brief
January 2012Ibuprofen Sector In Spain And Denmark
February 2012The Spanish Drug Industry
August 2012» Read our Company Profiles
1 CompaniesGlaxoSmithKline P.L.C.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
